Preface |
|
ix | |
Authors |
|
xi | |
Abbreviations |
|
xiii | |
Reference Ranges for Common Investigations |
|
xv | |
|
Section 1 Basic Principles |
|
|
|
Case 1 The Cytochrome P450 System |
|
|
3 | (4) |
|
Case 2 Therapeutic Levels |
|
|
7 | (2) |
|
|
9 | (2) |
|
|
11 | (2) |
|
Case 5 Monoclonal Antibody Therapy |
|
|
13 | (2) |
|
Case 6 Ligand-Gated Ion Channels |
|
|
15 | (4) |
|
|
19 | (2) |
|
|
21 | (2) |
|
|
23 | (4) |
|
|
27 | (2) |
|
Case 11 Renin-Angiotensin-Aldosterone Axis |
|
|
29 | (4) |
|
|
33 | (4) |
|
|
37 | (4) |
|
Case 14 Dose-Response Curves |
|
|
41 | (2) |
|
Case 15 G-Protein-Coupled Receptors |
|
|
43 | (6) |
|
|
|
|
49 | (2) |
|
|
51 | (2) |
|
Case 18 Managing Nausea and Vomiting |
|
|
53 | (2) |
|
|
55 | (2) |
|
Case 20 Managing Delirium |
|
|
57 | (2) |
|
|
59 | (4) |
|
|
63 | (2) |
|
|
65 | (2) |
|
Case 24 Anti-Epileptics in Pregnancy |
|
|
67 | (2) |
|
Case 25 Treating Macrocytic Anaemias |
|
|
69 | (4) |
|
Section 3 Prescribing Cases |
|
|
|
|
73 | (2) |
|
Case 27 Adverse Drug Reactions 1 |
|
|
75 | (2) |
|
|
77 | (4) |
|
|
81 | (2) |
|
Case 30 Planning Management 1 |
|
|
83 | (2) |
|
Case 31 Calculation Skills 1 |
|
|
85 | (2) |
|
Case 32 Adverse Drug Reactions 2 |
|
|
87 | (2) |
|
|
89 | (2) |
|
|
91 | (2) |
|
Case 35 Planning Management 2 |
|
|
93 | (2) |
|
|
95 | (2) |
|
Case 37 Calculation Skills 2 |
|
|
97 | (2) |
|
|
99 | (2) |
|
|
101 | (3) |
|
|
104 | (3) |
|
Case 41 Prescription Review 1 |
|
|
107 | (2) |
|
|
109 | (2) |
|
Case 43 Planning Management 3 |
|
|
111 | (2) |
|
Case 44 Prescription Review 2 |
|
|
113 | (2) |
|
Case 45 Planning Management 4 |
|
|
115 | (2) |
|
Case 46 Planning Management 5 |
|
|
117 | (2) |
|
Case 47 Providing Information 1 |
|
|
119 | (2) |
|
Case 48 Calculation Skills 3 |
|
|
121 | (2) |
|
Case 49 Calculation Skills 4 |
|
|
123 | (2) |
|
Case 50 Adverse Drug Reactions 3 |
|
|
125 | (2) |
|
Case 51 Data Interpretation 1 |
|
|
127 | (2) |
|
Case 52 Planning Management 6 |
|
|
129 | (2) |
|
Case 53 Drug Monitoring 1 |
|
|
131 | (2) |
|
|
133 | (2) |
|
Case 55 Prescription Review 3 |
|
|
135 | (2) |
|
Case 56 Prescription Review 4 |
|
|
137 | (2) |
|
Case 57 Planning Management 7 |
|
|
139 | (2) |
|
Case 58 Drug Monitoring 2 |
|
|
141 | (2) |
|
Case 59 Data Interpretation 2 |
|
|
143 | (2) |
|
Case 60 Planning Management 8 |
|
|
145 | (2) |
|
Case 61 Calculation Skills 5 |
|
|
147 | (2) |
|
Case 62 Providing Information 2 |
|
|
149 | (2) |
|
|
151 | (2) |
|
Case 64 Prescription Review 5 |
|
|
153 | (2) |
|
|
155 | (2) |
|
Case 66 Drug Monitoring 3 |
|
|
157 | (2) |
|
Case 67 Data Interpretation 3 |
|
|
159 | (2) |
|
Case 68 Adverse Drug Reactions 4 |
|
|
161 | (2) |
|
Case 69 Calculation Skills 6 |
|
|
163 | (2) |
|
Case 70 Providing Information 3 |
|
|
165 | (2) |
|
Case 71 Prescription Review 6 |
|
|
167 | (2) |
|
Case 72 Drug Monitoring 4 |
|
|
169 | (2) |
|
Case 73 Drug Monitoring 5 |
|
|
171 | (2) |
|
Case 74 Data Interpretation 4 |
|
|
173 | (2) |
|
Case 75 Adverse Drug Reactions 5 |
|
|
175 | (2) |
|
|
177 | (2) |
|
Case 77 Providing Information 4 |
|
|
179 | (2) |
|
Case 78 Prescription Review 7 |
|
|
181 | (3) |
|
|
184 | (3) |
|
Case 80 Drug Monitoring 6 |
|
|
187 | (2) |
|
Case 81 Data Interpretation 5 |
|
|
189 | (2) |
|
Case 82 Adverse Drug Reactions 6 |
|
|
191 | (2) |
|
Case 83 Calculation Skills 7 |
|
|
193 | (2) |
|
Case 84 Providing Information 5 |
|
|
195 | (2) |
|
|
197 | (2) |
|
Case 86 Drug Monitoring 7 |
|
|
199 | (2) |
|
Case 87 Data Interpretation 6 |
|
|
201 | (2) |
|
Case 88 Planning Management 9 |
|
|
203 | (2) |
|
Case 89 Calculation Skills 8 |
|
|
205 | (2) |
|
Case 90 Planning Management 10 |
|
|
207 | (2) |
|
|
209 | (2) |
|
Case 92 Data Interpretation 7 |
|
|
211 | (2) |
|
Case 93 Adverse Drug Reactions 7 |
|
|
213 | (2) |
|
Case 94 Providing Information 6 |
|
|
215 | (2) |
|
Case 95 Providing Information 7 |
|
|
217 | (2) |
|
Case 96 Drug Monitoring 8 |
|
|
219 | (2) |
|
Case 97 Prescription Review 8 |
|
|
221 | (2) |
|
Case 98 Adverse Drug Reactions 8 |
|
|
223 | (2) |
|
Case 99 Planning Management 11 |
|
|
225 | (2) |
|
Case 100 Prescription Review 9 |
|
|
227 | (2) |
Index |
|
229 | |